Number of Lymph Nodes Examined as a Prognosis Factor in Patients With Stage II or III Colon Cancer.
Saved in:
| Title: | Number of Lymph Nodes Examined as a Prognosis Factor in Patients With Stage II or III Colon Cancer. |
|---|---|
| Authors: | Kim H; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea., Shen L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Jeon J; Yonsei University College of Medicine, Seoul, South Korea., Han YD; Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea., Han DH; Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea., Jung M; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea., Shin SJ; Institute for Innovation in Digital Healthcare, Yonsei University Health System, Seoul, South Korea., You SC; Institute for Innovation in Digital Healthcare, Yonsei University Health System, Seoul, South Korea; Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea., Kim NK; Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea., Min BS; Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea., Hur H; Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea., Ahn JB; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea., Shin SJ; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea., van Gestel AJ; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., van Erning FN; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Geleijnse G; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands. Electronic address: G.Geleijnse@iknl.nl., Kim HS; Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Institute for Innovation in Digital Healthcare, Yonsei University Health System, Seoul, South Korea; Graduate School of Medical Science, Brain Korea 21 FOUR Project, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: modeerfhs@yuhs.ac. |
| Source: | Clinical colorectal cancer [Clin Colorectal Cancer] 2025 Jun; Vol. 24 (2), pp. 280-289.e4. Date of Electronic Publication: 2025 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1938-0674 |
|---|---|
| DOI: | 10.1016/j.clcc.2025.02.004 |
